FDA flags chlorthalidone blood pressure pills in second Inventia recall
Inventia Healthcare is recalling more than 13,000 bottles of chlorthalidone tablets after they failed dissolution testing, marking the company’s second recall of…
Subject
What's happening with dissolution testing
Current status
Inventia Healthcare Limited is recalling 13,567 bottles of Chlorthalidone Tablets, USP, 25 mg after the pills failed dissolution testing, a quality check that measures how the drug breaks down in the body.The recalled bottles are part of a blood pressure medication sold in 100-tablet and 1,000-tablet sizes, with an expiration date of April 2027. The FDA has identified the recall as Class II, which means the product may cause temporary or medically reversible adverse health consequences, while serious harm is considered remote.Chlorthalidone is a diuretic, or water pill, used to lower blood pressure by helping the kidneys remove salt and water.
Latest update
— FDA flags chlorthalidone blood pressure pills in second Inventia recall
Related subjects
Stories